This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Guardian Medical USA, a company focused on sterile barrier packaging for the orthopedics medical device market, has successfully raised more than $2 million in recent private financing.
The capital raise was led by Queen City Angels (Cincinnati, Ohio). Key investors are Jump Start, Rocket Innovations Holdings, and Lateral Capital VI, in addition to numerous individual investors associated with Queen City Angels.
“Guardian Medical USA has been making steady progress in gaining key customers in the spine, foot and ankle, and trauma orthopedic market segments,” says Guardian Medical USA CEO Tracy Momany. “This funding allows us to accelerate our product development and facilities growth to meet upcoming demand and significant interest in using rigid tubes to sterile package orthopedic implants and devices of all types and sizes.”
“Our investment in Guardian Medical USA is consistent with our mission to support high-growth companies having disruptive technology, across the state of Ohio,” says Queen City Angels lead investor, Ted Capossela.
“In combination with Jump Start, Rocket Innovations, and Lateral Capital, we are proud to have invested in Guardian Medical USA, a ‘hometown’ company that has a significant market opportunity in the medical device market,” says Ross Bushman, a Queen City Angels investor member and Guardian Medical board member.
Since its inception, Guardian Medical USA has invested in creating a sterile tube packaging system, CapSure™, with a pre-validated seal having unequaled functional characteristics and abilities. The company has its own automated implant cleaning line and Class 7 cleanroom for packaging. The company meets the requisite ISO 13485 and packaging standards for sterile barrier medical device packaging.
